Stocks/Funds/CIK 2050709

Squadron Capital Management LLC

Quarterly 13F filings · Latest period 2026-03-31 · CIK 2050709
Assets
$250M
Holdings
30
Lifetime alpha vs market
+92.21% annual
Average hold time
0.4 yr
median 0.5 yr

Quarterly history

Cum return +13% vs S&P -4% · α +17% lifetimeAUM $250M · peak $250MFlow $-2M (-1%)2025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
-33.12%
trims when stocks drop
when a holding falls −10%+
Middle response
+0.95%
steady accumulation
Rally response
+18.66%
adds into rallies
when a holding rises +10%+

Top positions · 30

Ticker$ value% portYoYHold time
RLMDRelmada Therapeutics, In$59M23.6%0.5 yr
COGTCogent Biosciences, Inc.$30M12.1%0.5 yr
KALVKalVista Pharmaceuticals$20M7.9%0.5 yr
KODKodiak Sciences Inc.$14M5.8%0.5 yr
ABVXAbivax S.A.$14M5.8%0.5 yr
EWTXEdgewise Therapeutics, I$11M4.4%0.5 yr
NKTRNektar Therapeutics$9M3.6%0.3 yr
ANLAdlai Nortye Ltd.$9M3.5%0.3 yr
ZNTLZentalis Pharmaceuticals$8M3.4%0.3 yr
MAZEMaze Therapeutics, Inc.$8M3.1%0.5 yr
SCYXSCYNEXIS, Inc.$7M2.8%0.3 yr
RLAYRelay Therapeutics, Inc.$7M2.7%0.3 yr
CCCCC4 Therapeutics, Inc.$6M2.4%0.3 yr
$6M2.4%0.5 yr
$5M2.1%0.5 yr

Portfolio composition (YoY)

Industry mix
Biotechnology86.6%$216M
Unknown10.1%$25M
Drug Manufacturers - Specialty & Generic3.1%$8M
Medical - Pharmaceuticals0.1%$0M
Country
US76.6%
Unknown10.1%
FR7.0%
KY3.5%
IE1.8%
IL1.0%
Top 5: 55.2% · Top 10: 73.2% · Top 25: 98.7%

Winners

TickerPrev $PnLYoY %

Losers

TickerPrev $PnLYoY %

Top buys this quarter · 15

RLMD Relmada Therapeutics, Inc.+$12M
NKTR Nektar Therapeuticsnew+$9M
ANL Adlai Nortye Ltd.new+$9M
ZNTL Zentalis Pharmaceuticals, Inc.new+$8M
SCYX SCYNEXIS, Inc.new+$7M
RLAY Relay Therapeutics, Inc.new+$7M
CCCC C4 Therapeutics, Inc.new+$6M
KALV KalVista Pharmaceuticals, Inc.+$6M
KOD Kodiak Sciences Inc.+$3M
ALXO ALX Oncology Holdings Inc.new+$3M

Top sells this quarter · 15

MAZE Maze Therapeutics, Inc.$7M
XENE Xenon Pharmaceuticals Inc.exit$6M
VTYX Ventyx Biosciences, Inc.exit$6M
TARS Tarsus Pharmaceuticals, Inc.exit$6M
BLTE Belite Bio, Incexit$4M
SPRB Spruce Biosciences, Inc.$4M
CMPS COMPASS Pathways plcexit$2M
UPB Upstream Bio, Inc.exit$2M
ABVX Abivax S.A.$2M
WVE Wave Life Sciences Ltd.exit$1M

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$250M30+12.60%-4.37%+16.97%-0.00B
2025-12-31$224M29